UPDATE: Piper Jaffray On OPKO Health Is 'Confident in Somatrogon Approval'; Firm Projects Co's 'U.S. net Rayaldee sales to grow from $27.4 million this year to $40 million in 2020 and $52.5 million in 2021'; Notes 'BioReference and GeneDx Stabilizing'